Back
ProShares Ultra Nasdaq Biotechnology Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
5
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
$36.10
Seasonality Move:
11.41%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing slight buying pressure.
ProShares Ultra Nasdaq Biotechnology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.94 | Sell |
20-day SMA: | 50.18 | Sell |
50-day SMA: | 53.13 | Sell |
200-day SMA: | 58.93 | Sell |
8-day EMA: | 45.03 | Sell |
20-day EMA: | 48.82 | Sell |
50-day EMA: | 51.85 | Sell |
200-day EMA: | 56.03 | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.03 | Sell |
Relative Strength Index (14 RSI): | 22.84 | Sell |
Chaikin Money Flow: | 4165 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.77 - 55.11) | Sell |
Bollinger Bands (100): | (49.99 - 58.53) | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ProShares Ultra Nasdaq Biotechnology Stock
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 39.41 while BIB 8-day simple moving average is 45.94, which is a Sell signal.
-
The stock price of BIB is 39.41 while ProShares Ultra Nasdaq Biotechnology 20-day SMA is 50.18, which makes it a Sell.
-
ProShares Ultra Nasdaq Biotechnology 50-day simple moving average is 53.13 while BIB share price is 39.41, making it a Sell technically.
-
BIB stock price is 39.41 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 58.93, creating a Sell signal.
BIB Technical Analysis vs Fundamental Analysis
Sell
5
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a SellThe current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $39.41. The Score for BIB is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
ProShares Ultra Nasdaq Biotechnology Stock Info
Market Cap:
0
Price in USD:
39.41
Share Volume:
22.4K
ProShares Ultra Nasdaq Biotechnology 52-Week Range
52-Week High:
69.56
52-Week Low:
36.22
Sell
5
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
ProShares Ultra Nasdaq Biotechnology Share Price Forecast
-
What is the ProShares Ultra Nasdaq Biotechnology stock price today?The ProShares Ultra Nasdaq Biotechnology stock price is 39.41 USD today.
-
Will BIB stock go up or go down?ProShares Ultra Nasdaq Biotechnology> share price is forecast to RISE/FALL based on technical indicators
-
Is ProShares Ultra Nasdaq Biotechnology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProShares Ultra Nasdaq Biotechnology is overvalued.
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 39.41 while BIB 8-day exponential moving average is 45.03, which is a Sell signal.
-
The stock price of BIB is 39.41 while ProShares Ultra Nasdaq Biotechnology 20-day EMA is 48.82, which makes it a Sell.
-
ProShares Ultra Nasdaq Biotechnology 50-day exponential moving average is 51.85 while BIB share price is 39.41, making it a Sell technically.
-
BIB stock price is 39.41 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 56.03, creating a Sell signal.
Technical Analysis of ProShares Ultra Nasdaq Biotechnology
Should I short ProShares Ultra Nasdaq Biotechnology stock?
-
BIB Moving Average Covergence Divergence (MACD) indicator is -3.03, suggesting ProShares Ultra Nasdaq Biotechnology is a Sell
-
ProShares Ultra Nasdaq Biotechnology Relative Strength Index (RSI) is 22.84, which suggest ProShares Ultra Nasdaq Biotechnology is oversold
-
The Bollinger Bands (25) for ProShares Ultra Nasdaq Biotechnology is (46.77 - 55.11), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
-
The Bollinger Bands (100) for ProShares Ultra Nasdaq Biotechnology is (49.99 - 58.53), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.